Exicure

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exicure and other ETFs, options, and stocks.

About XCUR

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. 

CEO
Andy Yoo
CEOAndy Yoo
Employees
7
Employees7
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2011
Founded2011
Employees
7
Employees7

XCUR Key Statistics

Market cap
23.14M
Market cap23.14M
Price-Earnings ratio
-2.47
Price-Earnings ratio-2.47
Dividend yield
Dividend yield
Average volume
12.23K
Average volume12.23K
High today
$3.69
High today$3.69
Low today
$3.49
Low today$3.49
Open price
$3.69
Open price$3.69
Volume
10.01K
Volume10.01K
52 Week high
$36.00
52 Week high$36.00
52 Week low
$2.75
52 Week low$2.75

Stock Snapshot

The current Exicure(XCUR) stock price is $3.62, with a market capitalization of 23.14M. The stock trades at a price-to-earnings (P/E) ratio of -2.47.

On 2025-11-17, Exicure(XCUR) stock moved within a range of $3.49 to $3.69. With shares now at $3.62, the stock is trading +3.7% above its intraday low and -1.9% below the session's peak.

Trading volume for Exicure(XCUR) stock has reached 10.01K, versus its average volume of 12.23K.

The stock's 52-week range extends from a low of $2.75 to a high of $36.00.

The stock's 52-week range extends from a low of $2.75 to a high of $36.00.

People also own

Based on the portfolios of people who own XCUR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.